RISK ANALYSIS IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROME

摘要

The present invention relates to a method for identifying a subject being susceptible to a metabolic syndrome related therapy based on determining the amounts of adiponectin, retinol binding protein 4 and proinsulin in a sample of a subject, and comparing the, thus, determined amounts to suitable reference amounts. Moreover, the present invention relates to a method for predicting the risk of developing a metabolic syndrome in an apparently healthy subject based on determining the aforementioned markers in a sample of said subject. Also encompassed by the present invention are kits and devices adapted to carry out the methods of the present invention.